Form 4: Insuleet Corp Executive VP Benjamin Eric Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Executive VP Benjamin Eric reports exercising stock options and selling shares of Insuleet Corp common stock on January 21, 2025, according to a Form 4 filing.
Summary
- On January 21, 2025, Benjamin Eric, Executive VP of Insulet Corp, exercised employee stock options to acquire 1,704 shares at $46.22 and 3,371 shares at $74.50.
- He then sold 12,394 shares of common stock at $280.
- Following these transactions, Benjamin Eric directly owns 11,383 shares of common stock.
- He also holds options to purchase 3,271 and 1,875 shares of common stock at exercise prices of $46.22 and $74.50 respectively.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The vesting schedule described (25% after one year, then quarterly) is a typical arrangement.
- Similar filings are made by executives at companies like Medtronic, Dexcom, and Abbott, which are competitors in the medical device space.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, depending on the overall market perception of the transaction.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of stock option exercise and stock sale. |
| 02/22/2027 | Expiration date of employee stock option (Right to Buy) with exercise price of $46.22. |
| 02/14/2028 | Expiration date of employee stock option (Right to Buy) with exercise price of $74.5. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.